Mycorena to build mycoprotein production plant in Sweden
Type of post: NEWS IN BRIEF.
Mycorena AB and Falkenbergsgruppen AB have announced a joint project to establish a facility for large-scale production of fungi-based protein. The factory is to be built by the co-owned company Mycorena Fastighets AB and will be operational during 2022.
Press release: “First-of-its-kind facility for mycoprotein production to be built in Falkenberg”, 27/04/2021.
Figure 1. Mycorena to build mycoprotein production plant in Falkenberg (taken from the press release)
The factory’s purpose is to industrialize Mycorena’s manufacturing of Promyc, a unique fungi-based protein source sold to food producers all over the world. The Gothenburg-based company currently operates pilot-scale production and sales in its home city, but has now chosen to establish their first large-scale facility in Falkenberg.
The establishment has been made possible by large efforts on research and development of Mycorena’s technology, which consists of a fermentation process not unlike beer brewing. In this work, the company has had great help from FBG Invest, an investor network supplying entrepreneurs with local venture capital. Members of the network have been a part of Mycorena’s journey for more than a year, and several are involved in both Falkenbergsgruppen Fastighets AB and Mycorena Fastighets AB.
After completion of the project, the facility will operate as a model factory for Mycorena’s continued growth, as well as a global research and innovation center for the company. It will lay the foundation for expansion of the production concept both in Sweden and internationally, and the goal is to supply the food industry with tens of thousands of tons Promyc before the year 2030.
